Return to Stock Page

Income Statement

Metrics20202021202220222023
Revenue & Cost
Total Revenue$4.06M$11.91M$-17.81M$-3.54M$7.46M
Cost of Revenue$0.00$0.00$0.00$-10.63M$1.20M
Gross Profit$0.00$0.00$-17.81M$7.10M$6.26M
Gross Margin %0.00%0.00%100.00%-200.52%83.95%
Operating Expenses
R&D Expenses$0.00$0.00---
SG&A Expenses$147.79K$146.48K$141.09K$151.63K$1.31M
Other Operating Expenses$789.00$2.45K$2.56K$-3.15M-
Total Operating Expenses$148.58K$148.93K$143.65K$153.56K$1.31M
Operating Performance
Operating Income$0.00$0.00$-17.21M$5.77M$6.16M
Operating Margin %0.00%0.00%96.63%-162.98%82.49%
EBITDA$5.48M$12.45M$-17.21M$-9.46M-
EBITDA Margin %135.15%104.50%96.63%267.32%-
Other Income/Expenses
Interest Expense$1.58M$684.64K$743.63K$2.32M$3.25M
Other Income/Expenses Net$0.00$0.00$-743.63K$-9.46M$-3.58M
Income Before Tax$3.91M$11.76M$-17.96M$-3.69M$2.57M
Income Tax Expense$0.00$0.00-$-9.46M-
Net Performance
Net Income$3.91M$11.76M$-17.96M$-3.69M$2.57M
Net Margin %96.34%98.75%100.81%104.34%34.46%
EPS$0.42$1.26$-1.92$-0.40$0.28
Diluted EPS$0.42$1.26$-1.92$-0.40$0.28

Financial Visualization

Balance Sheet

Metrics20202021202220222023
Assets
Current Assets
Cash & Cash Equivalents$1.97M-$7.45M$2.34M$103.03K
Short Term Investments---$1.50M$2.00M
Net Receivables$2.92M$4.36M$2.77M$2.80M$2.70M
Inventory---$6.64M-
Other Current Assets---$-6.64M$-4.81M
Total Current Assets--$10.22M$5.14M$2.81M
Non-Current Assets
Property, Plant & Equipment (Net)-----
Long Term Investments$205.99M$214.12M$185.51M$183.98M$183.56M
Tax Assets-----
Other Non-Current Assets--$-185.51M$-183.98M$15.25K
Total Non-Current Assets--$185.51M$183.98M$183.57M
Total Assets
Total Assets$210.89M$218.49M$195.74M$189.14M$186.38M
Liabilities
Current Liabilities
Accounts Payable$403.31K$418.12K$1.44M$2.17M$376.19K
Short Term Debt----$17.24K
Tax Payables-----
Deferred Revenue----$-393.43K
Other Current Liabilities--$-1.44M$152.36K$121.59K
Total Current Liabilities--$1.44M$2.32M$497.77K
Non-Current Liabilities
Long Term Debt-$881.39K-$73.77M$73.78M
Other Non-Current Liabilities--$1.44M$-73.77M$-73.78M
Total Non-Current Liabilities-$881.39K$1.44M$73.77M$73.78M
Total Liabilities
Total Liabilities$74.31M$75.25M$75.35M$76.08M$74.28M
Shareholders Equity
Equity Components
Common Stock$93.23K$93.23K$93.25K$93.25K$93.25K
Retained Earnings$7.19M$13.87M$-9.00M$-16.32M$-16.89M
Accumulated Other Comprehensive Income/Loss---$-16.32M$-16.89M
Total Shareholders Equity$136.57M$143.24M$120.39M$113.06M$112.10M
Key Metrics
Balance Check
Total Liabilities & Equity$210.89M$218.49M$195.74M$189.14M$186.38M
Total Debt-$881.39K-$73.77M$73.80M
Net Debt$-1.97M$881.39K$-7.45M$71.43M$73.69M

Balance Sheet Analysis

Cash Flow Statement

Metrics20202021202220222023
Operating Activities
Core Operations
Net Income$3.91M$11.76M$-17.96M$-3.69M$2.57M
Depreciation & Amortization----$9.78K
Stock Based Compensation-----
Working Capital Changes
Change in Accounts Receivable---$-30.83K$94.21K
Change in Inventory---$-867.52K-
Change in Accounts Payable---$867.52K$-1.94M
Other Working Capital Changes---$869.55K$-7.43K
Total Working Capital Change$66.14K$-1.41M$2.59M$838.72K$-1.85M
Other Operating
Other Non-Cash Items$3.14M$-8.13M$28.63M$1.54M$3.32M
Net Cash from Operations$7.12M$2.23M$13.26M$-1.32M$2.19M
Investing Activities
Capital Investments
Capital Expenditures----$-1.00
Purchase of Investments---$-50.27M$-41.41M
Sale of Investments---$44.39M$40.87M
Other Investing Activities-----
Net Cash from Investing---$-5.88M$-535.09K
Financing Activities
Debt & Equity
Debt Repayment$-1.02M$-463.17K$-999.28K$-1.32M$-1.56K
Stock Repurchases-----
Dividends Paid$-4.59M$-5.08M$-4.92M$-3.80M$-3.39M
Other Financing Activities$459.43K$1.34M$117.89K$1.32M-
Net Cash from Financing$-5.15M$-4.19M$-5.80M$-3.80M$-3.39M
Cash Position
Summary
Net Change in Cash$-5.15M$-4.19M$7.45M$-5.11M$-2.24M
Cash at Beginning of Period-$1.97M-$7.45M$2.34M
Cash at End of Period$1.97M-$7.45M$2.34M$103.03K
Key Metrics
Operating Cash Flow$7.12M$2.23M$13.26M$-1.32M$2.19M
Capital Expenditure----$-1.00
Free Cash Flow$7.12M$2.23M$13.26M$-1.32M$2.19M

Cash Flow Analysis